日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity

有丝分裂抑制剂MTH1 karonudib 可杀死上皮性卵巢癌细胞,且该作用与铂类药物敏感性无关。

Hurley, Rachel M; Wagner, Jill M; Kanakkanthara, Arun; Venkatachalam, Annapoorna; Deisinger, Aaron M; Correia, Cristina; Schneider, Paula A; Peterson, Kevin L; Macon, Elaine P; Heinzen, Ethan P; Sanjiv, Kumar; Hou, Xiaonan; Becker, Marc A; Maurer, Matthew J; Larson, Melissa C; Swisher, Elizabeth M; Li, Hu; Oberg, Ann L; Weroha, S John; Berglund, Ulrika Warpman; Helleday, Thomas; Kaufmann, Scott H; Hendrickson, Andrea E Wahner

Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance

密码子特异性通读是获得性PARP抑制剂和化疗耐药中BRCA2恢复的机制。

McGehee, Cordelia D; Meng, X Wei; Wu, Xinyan; Correia, Cristina; Venkatachalam, Annapoorna; Flatten, Karen S; Peterson, Kevin L; Patel, Anand G; Rossman, Olivia K; Wong, Clara; Hurley, Rachel M; Wagner, Jill M; Schneider, Paula A; Dai, Haiming; Poirier, Guy G; Hendrickson, Andrea E Wahner; Swisher, Elizabeth M; Pandey, Akhilesh; Li, Hu; Kaufmann, Scott H

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

一项针对携带 BRCA1 或 BRCA2 突变的癌症患者或铂类耐药性卵巢癌或三阴性乳腺癌患者的长期单药维利帕尼 (ABT-888) 的 I 期药效学研究

Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji, Jiuping; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H

Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

获得性 RAD51C 启动子甲基化缺失导致高级别浆液性卵巢癌对 PARP 抑制剂产生耐药性

Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander; Wakefield, Matthew J; Scott, Clare L

CHFR and Paclitaxel Sensitivity of Ovarian Cancer

CHFR 和紫杉醇对卵巢癌的敏感性

Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hou, Xiaonan; Goergen, Krista M; Atkinson, Hunter J; Beito, Thomas G; Negron, Vivian; Lingle, Wilma L; Bruzek, Amy K; Hurley, Rachel M; Wagner, Jill M; Flatten, Karen S; Peterson, Kevin L; Schneider, Paula A; Larson, Melissa C; Maurer, Matthew J; Kalli, Kimberly R; Oberg, Ann L; Weroha, S John; Kaufmann, Scott H

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

PARP抑制剂尼拉帕尼在同源重组缺陷型和功能型卵巢癌中的体内抗肿瘤活性

AlHilli, Mariam M; Becker, Marc A; Weroha, S John; Flatten, Karen S; Hurley, Rachel M; Harrell, Maria I; Oberg, Ann L; Maurer, Matt J; Hawthorne, Kieran M; Hou, Xiaonan; Harrington, Sean C; McKinstry, Sarah; Meng, X Wei; Wilcoxen, Keith M; Kalli, Kimberly R; Swisher, Elizabeth M; Kaufmann, Scott H; Haluska, Paul

Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.

通过抑制肿瘤细胞侵袭驱动因子Vav1来靶向治疗胰腺癌转移

Razidlo Gina L, Magnine Christopher, Sletten Arthur C, Hurley Rachel M, Almada Luciana L, Fernandez-Zapico Martin E, Ji Baoan, McNiven Mark A